Phase 3 N=84 Randomized Quadruple-blind Treatment

Effect of Dexamethasone on Labor Induction

Dexamethasone · Pregnancy

Bottom Line

View on ClinicalTrials.gov: NCT05070468 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Dec 2024

Primary outcome: Primary: First Bishop Score — 1; 1 score on a scale — p=0.618

Study Design & Population

Study type: Interventional
Phase: Phase 3
Interventions: Dexamethasone 0.5mg (Drug); Placebo (Drug)
Age: Adult · 18+ yrs
Sex: Female
Sponsor: Alborz Medical University
Primary completion: Jan 2021

Outcome Measures

Outcome	Result	p-value
PRIMARY First Bishop Score	1; 1	0.618
PRIMARY Second Bishop Score	3.5; 3	0.483
PRIMARY The Latent Phase of Labor	4; 5	0.571

Summary

Pregnant women with a gestational age of 38 weeks and older admitted to Labor Of Kamali Hospital, for termination of pregnancy, by accident and based on the a statistician did coding to identify groups of users of pill A or pill B, 14 pills are used vaginally. The patients and the researcher is blinded and the pharmacist delivers the dexamethasone and placebo tablets with codes A and B to the researcher.

Eligibility Criteria

Inclusion Criteria

Iranian Women
Primigravid pregnancy
Normal of Body Mass Index
Single Pregnancy
presentation cephalic in sonography
Gestational age 38 weeks
Bishop score 2 and less
Normal Non Stress
Test Estimate of Fetus Weight 2500-4000 gr
Didn't take hormonal, herbal and chemical drugs
having a healthy water bag

Exclusion Criteria

Have Medicine And Midwifery Complication
Lack of Desire for Cooperation
Fetal Immobility
Maternal Bleeding

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05070468). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.